Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Alexander Vlaar and Frederique Paulus.
Alexander Vlaar
Connection Strength
0.504
Frederique Paulus
  1. Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial. Lancet Rheumatol. 2020 Dec; 2(12):e764-e773.
    View in: PubMed
    Score: 0.226
  2. Assessment of Lung Reaeration at 2 Levels of Positive End-expiratory Pressure in Patients With Early and Late COVID-19-related Acute Respiratory Distress Syndrome. J Thorac Imaging. 2021 Sep 01; 36(5):286-293.
    View in: PubMed
    Score: 0.060
  3. Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study. Lancet Respir Med. 2021 02; 9(2):139-148.
    View in: PubMed
    Score: 0.057
  4. PRactice of VENTilation in Patients with Novel Coronavirus Disease (PRoVENT-COVID): rationale and protocol for a national multicenter observational study in The Netherlands. Ann Transl Med. 2020 Oct; 8(19):1251.
    View in: PubMed
    Score: 0.057
  5. Subphenotyping Acute Respiratory Distress Syndrome in Patients with COVID-19: Consequences for Ventilator Management. Ann Am Thorac Soc. 2020 09; 17(9):1161-1163.
    View in: PubMed
    Score: 0.056
  6. RELAx - REstricted versus Liberal positive end-expiratory pressure in patients without ARDS: protocol for a randomized controlled trial. Trials. 2018 May 09; 19(1):272.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.